BLCM - Bellicum Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 569.93M
Enterprise Value 339.79M
Trailing P/E N/A
Forward P/E 1-0.89
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)47.19
Price/Book (mrq)1.34
Enterprise Value/Revenue 326.85
Enterprise Value/EBITDA 6-0.44

Trading Information

Stock Price History

Beta (3Y Monthly) 1.74
52-Week Change 3-77.56%
S&P500 52-Week Change 36.34%
52 Week High 37.2700
52 Week Low 31.4850
50-Day Moving Average 31.8406
200-Day Moving Average 32.8713

Share Statistics

Avg Vol (3 month) 3641.73k
Avg Vol (10 day) 3517.15k
Shares Outstanding 533.29M
Float 40.96M
% Held by Insiders 15.24%
% Held by Institutions 153.79%
Shares Short (Jun 28, 2019) 44.22M
Short Ratio (Jun 28, 2019) 45.21
Short % of Float (Jun 28, 2019) 49.39%
Short % of Shares Outstanding (Jun 28, 2019) 49.17%
Shares Short (prior month May 31, 2019) 43.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,560.73%

Management Effectiveness

Return on Assets (ttm)-54.13%
Return on Equity (ttm)-170.41%

Income Statement

Revenue (ttm)1.48M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)235.10%
Gross Profit (ttm)-70.47M
EBITDA -90.17M
Net Income Avi to Common (ttm)-99.72M
Diluted EPS (ttm)-2.3230
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)73.48M
Total Cash Per Share (mrq)1.6
Total Debt (mrq)42.42M
Total Debt/Equity (mrq)83.42
Current Ratio (mrq)4.74
Book Value Per Share (mrq)1.13

Cash Flow Statement

Operating Cash Flow (ttm)-80.67M
Levered Free Cash Flow (ttm)-42.21M